RetinalGenix Technologies (RTGN) Other Gross PP&E Adjustments (2024 - 2026)
RetinalGenix Technologies' (RTGN) quarterly Other Gross PP&E Adjustments came in at -$3630.0 in Q1 2026, up 41.39% year-on-year from -$2567.3 in Q1 2025, and up 99.84% quarter-over-quarter from -$2.2 million in Q4 2025.
RetinalGenix Technologies (RTGN) Other Gross PP&E Adjustments (2024 - 2026) Analysis & Trends
RetinalGenix Technologies has disclosed Other Gross PP&E Adjustments across 3 years of filings, most recently posting -$3630.0 for Q1 2026.
- Other Gross PP&E Adjustments for Q1 2026 came in at -$3630.0, up 41.39% year-over-year; the trailing twelve-month figure through Mar 2026 was -$3630.0 (up 41.39% YoY), and the FY2025 annual result was -$2.2 million, down 16.0% from the prior year.
- Other Gross PP&E Adjustments came in at -$3630.0 for Q1 2026 at RetinalGenix Technologies, up from -$2.2 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of -$3630.0 in Q1 2026 to a low of -$2.2 million in Q4 2025.
- The 3-year median for Other Gross PP&E Adjustments is -$6194.0 (2025), against an average of -$600726.9.
- Across the five-year window, Other Gross PP&E Adjustments declined 16.0% in 2025 and soared 41.39% in 2026, its largest moves.
- RetinalGenix Technologies' Other Gross PP&E Adjustments stood at -$1.9 million in 2024, then fell by 16.0% to -$2.2 million in 2025, then soared by 99.84% to -$3630.0 in 2026.
- The last three Other Gross PP&E Adjustments figures came in at -$3630.0 (Q1 2026), -$2.2 million (Q4 2025), and -$4914.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 23.14 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | - |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -405.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -547.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -99.30 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 5.30 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 2.39 Bn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 991.00 Mn |
| 10 | RetinalGenix Technologies | - | - | - | -3,630.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,630.00 |
| Mar 31, 2026 | -3,630.00 |
| Dec 31, 2025 | -2.24 Mn |
| Dec 31, 2025 | -2.24 Mn |
| Sep 30, 2025 | -4,914.00 |
| Sep 30, 2025 | -4,914.00 |
| Jun 30, 2025 | -5,554.00 |
| Jun 30, 2025 | -5,554.00 |
| Mar 31, 2025 | -6,194.00 |
| Mar 31, 2025 | -6,194.00 |
| Dec 31, 2024 | -1.93 Mn |
| Dec 31, 2024 | -1.93 Mn |
| Sep 30, 2024 | -7,689.00 |
| Sep 30, 2024 | -7,689.00 |